Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 5710131

[Changes in cycloserine].

N Isobe·S Seki
View original source ↗Export metadata ↓

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

CycloserineDrug StabilityHumidityJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

N Isobe, S Seki. 1968. [Changes in cycloserine].. https://pubmed.ncbi.nlm.nih.gov/5710131/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2001

Synergic activity of D-cycloserine and beta-chloro-D-alanine against Mycobacterium tuberculosis.

D-Cycloserine (DCS) is a peptidoglycan inhibitor. Although very effective against Mycobacterium tuberculosis, it is seldom employed in the management of this infection due to its high toxicity. beta-Chloro-D-alanine (another peptidoglycan inhibitor) reduces the MIC of DCS from 50 to 2.5 mg/L at a concentration significantly below its MIC for this organism. A reduction in bacterial viability and significant growth inhibition (as quantified by the X/Y quotient for the Bactec radiometric procedure) were observed with subinhibitory concentrations of both drugs. It is suggested that this powerful synergic effect should be the object of in vivo and eventually clinical trials.

Cycloserine↗